TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31143999

Group type: EXPERIMENTAL
Intervention: Enteral nutrition
Number of subjects: 165

Group type: COMPARATOR
Intervention: Parenteral nutrition
Number of subjects: 165
Study: 29502548

Group type: EXPERIMENTAL
Intervention: THC (10 mg) administered orally
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 27068138

Group type: EXPERIMENTAL
Intervention: Ahmed glaucoma valve model M4 (High density porous polyethylene)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Ahmed glaucoma valve model S2 (polypropylene)
Number of subjects: 42
Study: 25212234

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 40 mg for 24 months
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg for 24 months
Number of subjects: 361

Group type: COMPARATOR
Intervention: Non-ACS patients
Number of subjects: 361
Study: 22795340

Group type: EXPERIMENTAL
Intervention: Aspirin treatment
Number of subjects: 1001
Study: 20601740

Group type: EXPERIMENTAL
Intervention: Bovine colostrum (BC) 25 g per day for 10 weeks
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo (PL) isocaloric per day for 10 weeks
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Bovine colostrum (BC)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 53
Study: 17954554

Group type: EXPERIMENTAL
Intervention: Project Care (custody planning intervention)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 157
Study: 16282947

Group type: EXPERIMENTAL
Intervention: palivizumab (Synagis) 15 mg/kg, 5 monthly doses
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: palivizumab (Synagis)
Number of subjects: 55
Study: 12016180

Group type: EXPERIMENTAL
Intervention: Teacher led intervention (single lesson on emergency contraception)
Number of subjects: 3974

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 3974
Study: 10340686

Group type: EXPERIMENTAL
Intervention: Loxapine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Typical antipsychotic agents
Number of subjects: 0
Study: 8535541

Group type: EXPERIMENTAL
Intervention: Urapidil added to nifedipine SR
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Metoprolol added to nifedipine SR
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Urapidil after metoprolol
Number of subjects: 273

Group type: COMPARATOR
Intervention: Nifedipine SR monotherapy
Number of subjects: 273
Study: 1966794

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (LMWH), subcutaneous injection once daily
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo, subcutaneous injection once daily
Number of subjects: 70
Study: 345314

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Chlorpromazine
Number of subjects: 360

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 360
Study: 30305761

Group type: EXPERIMENTAL
Intervention: Psychological consultation (experimental group)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Routine preoperative information by a nurse (control group)
Number of subjects: 112
Study: 29039325

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Carbamazepine
Number of subjects: 60
Study: 25664701

Group type: EXPERIMENTAL
Intervention: Immediately loaded implants (test group)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Delayed loaded implants (control group)
Number of subjects: 30
Study: 24361986

Group type: EXPERIMENTAL
Intervention: Virtual reality system based on Kinect for balance training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 22036858

Group type: COMPARATOR
Intervention: Compliance with treatment guidelines (damage control, transfusions, mechanical ventilation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Moderate deviations from guidelines
Number of subjects: 0

Group type: COMPARATOR
Intervention: Noncompliance with tidal volume and plateau pressure targets within the ventilation protocol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Noncompliance with weaning guideline
Number of subjects: 0
Study: 19285524

Group type: EXPERIMENTAL
Intervention: 18-page follow-up postal questionnaire
Number of subjects: 1587

Group type: COMPARATOR
Intervention: 3-page follow-up postal questionnaire
Number of subjects: 1587
Study: 17326544

Group type: EXPERIMENTAL
Intervention: Auto-adjusting positive airway pressure (APAP)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Continuous positive airway pressure (CPAP)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Patient preference for device
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Follow-up after 18 months of therapy
Number of subjects: 29
Study: 16858169

Group type: EXPERIMENTAL
Intervention: Terbinafine 500 mg/d orally for 7 days
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Itraconazole 200 mg/d orally for 7 days
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Fluconazole 150 mg orally as a single dose
Number of subjects: 44
Study: 11927735

Group type: EXPERIMENTAL
Intervention: Intravenous ondansetron
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study: 9485128

Group type: EXPERIMENTAL
Intervention: LDL apheresis
Number of subjects: 64
Study: 8563868

Group type: EXPERIMENTAL
Intervention: Controlled-release mesalazine (1500 mg/day)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Sulfasalazine (3000 mg/day)
Number of subjects: 109
Study: 2539714

Group type: EXPERIMENTAL
Intervention: Enalapril (20 or 40 mg once daily)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 778569

Group type: EXPERIMENTAL
Intervention: Dihydergot (1.0 mg i.m.)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 31041805

Group type: EXPERIMENTAL
Intervention: Elastic band training programme (twice a week for 8 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no additional training)
Number of subjects: 30
Study: 28583116

Group type: EXPERIMENTAL
Intervention: CSF T-tau measured 1 year post-stroke
Number of subjects: 210
Study: 26037632

Group type: EXPERIMENTAL
Intervention: 450 ml beetroot juice (5.5 mmol nitrate)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 22817699

Group type: EXPERIMENTAL
Intervention: Transdermal tulobuterol patch (TP; 2 mg, once a day)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Inhaled salmeterol (50 µg, twice a day)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Transdermal tulobuterol patch (TP)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Inhaled salmeterol
Number of subjects: 44
Study: 22379796

Group type: EXPERIMENTAL
Intervention: OPP + PCIA
Number of subjects: 120

Group type: COMPARATOR
Intervention: PCIA
Number of subjects: 120
Study: 20108779

Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil 10 mg daily + Bicyclol 150 mg daily for 48 weeks
Number of subjects: 91

Group type: COMPARATOR
Intervention: Adefovir dipivoxil 10 mg daily alone for 48 weeks
Number of subjects: 91
Study: 16452737

Group type: EXPERIMENTAL
Intervention: DepoDur 20 mg
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: DepoDur 30 mg
Number of subjects: 168

Group type: COMPARATOR
Intervention: Sham epidural injection
Number of subjects: 168
Study: 15283931

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) containing 2 mg 17‐beta estradiol plus 1 mg norethisterone acetate daily for 6 months
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no HRT)
Number of subjects: 30
Study: 12713610

Group type: EXPERIMENTAL
Intervention: 500 mg ornidazole vaginal ovules (VO)
Number of subjects: 100

Group type: COMPARATOR
Intervention: 500 mg ornidazole vaginal tablets (VT)
Number of subjects: 100
Study: 10451129

Group type: EXPERIMENTAL
Intervention: 0.6 mg x kg(‐1) promethazine i.m. prior to discharge
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo i.m. prior to discharge
Number of subjects: 95
Study: 7775172

Group type: EXPERIMENTAL
Intervention: Dihydroergotamine nasal spray
Number of subjects: 206
Study: 2322789

Group type: EXPERIMENTAL
Intervention: 3 day Haemoccult
Number of subjects: 35184

Group type: EXPERIMENTAL
Intervention: 6 day Haemoccult
Number of subjects: 35184
Study: 7406099

Group type: EXPERIMENTAL
Intervention: Periodic telephone contact initiated by the Health Department
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 28917229

Group type: EXPERIMENTAL
Intervention: 33 g peanut butter (PBG)
Number of subjects: 37

Group type: COMPARATOR
Intervention: 16 g lard (LG)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 1 mg [13C10] retinyl acetate capsule (reference dose) with PBG
Number of subjects: 37

Group type: COMPARATOR
Intervention: 1 mg [13C10] retinyl acetate capsule (reference dose) with LG
Number of subjects: 37
Study: 25927483

Group type: COMPARATOR
Intervention: Spiromax after PIL training
Number of subjects: 200

Group type: COMPARATOR
Intervention: Spiromax after enhanced training
Number of subjects: 200

Group type: COMPARATOR
Intervention: Spiromax
Number of subjects: 200

Group type: COMPARATOR
Intervention: Turbuhaler
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both devices after enhanced training
Number of subjects: 200
Study: 23361105

Group type: EXPERIMENTAL
Intervention: EACA
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: HOE 140
Number of subjects: 115

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: EACA and HOE 140
Number of subjects: 115

Group type: COMPARATOR
Intervention: EACA, HOE 140, and Placebo
Number of subjects: 115
Study: 21165692

Group type: EXPERIMENTAL
Intervention: Group motivational interviewing (MI)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Group health promotion program
Number of subjects: 203
Study: 19674176

Group type: EXPERIMENTAL
Intervention: Educational intervention based on self‐completed instruments
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 53
Study: 16489694

Group type: EXPERIMENTAL
Intervention: 40 mg ritodrine sustained release capsules three times a day (study group, n=62)
Number of subjects: 120

Group type: COMPARATOR
Intervention: No treatment (control group, n=58)
Number of subjects: 120
Study: 14749094

Group type: EXPERIMENTAL
Intervention: Pregnenolone (15 mg PO per day for 2 weeks followed by 30 mg PO per day for 2 weeks)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Pregnenolone (N=5)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo (N=6)
Number of subjects: 17
Study: 11338300

Group type: EXPERIMENTAL
Intervention: Transoral lidocaine delivery system (LDS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Benzocaine-gel preparation (BGP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Non-anesthetic control
Number of subjects: 20
Study: 9390107

Group type: EXPERIMENTAL
Intervention: Itraconazole (200 mg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 8197085

Group type: EXPERIMENTAL
Intervention: Repeated courses of hyperbaric oxygenation (HBO)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Three courses of HBO therapy administered at 4 months intervals
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (8 IDDM patients, no treatment)
Number of subjects: 39
Study: 30093449

Group type: EXPERIMENTAL
Intervention: Alisertib tablets (60 mg/m2/dose × 7 days), irinotecan (50 mg/m2/dose i.v. × 5 days), and temozolomide (100 mg/m2/dose orally × 5 days)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Alisertib oral solution (45 mg/m2)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Alisertib tablets (60 mg/m2/dose)
Number of subjects: 32
Study: 26807896

Group type: EXPERIMENTAL
Intervention: Short breath-hold MR technique (CAIPIRINHA)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Long breath-hold MR technique (conventional VIBE)
Number of subjects: 119
Study: 24227801

Group type: EXPERIMENTAL
Intervention: 5 mg/mL TID pazopanib eye drops
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 2 mg/mL TID pazopanib eye drops
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 5 mg/mL QD pazopanib eye drops
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 70
Study: 22361799

Group type: EXPERIMENTAL
Intervention: Interviews conducted by a faculty member and a student (n = 2,345)
Number of subjects: 3868

Group type: COMPARATOR
Intervention: Interviews conducted by two faculty members (n = 1,523)
Number of subjects: 3868

Group type: EXPERIMENTAL
Intervention: Interviewer pairs structure (faculty vs. student involvement)
Number of subjects: 3868
Study: 20434603

Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA injections followed by 12 weeks of postinjection task practice with FES
Number of subjects: 23

Group type: COMPARATOR
Intervention: OnabotulinumtoxinA injections followed by 12 weeks of postinjection task practice without FES
Number of subjects: 23
Study: 18619772

Group type: EXPERIMENTAL
Intervention: Aerobic exercise withdrawal
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (continued regular exercise)
Number of subjects: 40
Study: 16874143

Group type: EXPERIMENTAL
Intervention: Home-based exercise training programme (Group A)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Generic instructions to maintain physical activity (Group B)
Number of subjects: 44
Study: 12784106

Group type: COMPARATOR
Intervention: Nicotine gum 2 mg
Number of subjects: 3

Group type: COMPARATOR
Intervention: Donepezil 5 mg/day for 30 days
Number of subjects: 3

Group type: COMPARATOR
Intervention: Alcohol (acute) after target peak BAC of 0.10%
Number of subjects: 3

Group type: COMPARATOR
Intervention: Alcohol (8 h carryover)
Number of subjects: 3
Study: 11166510

Group type: EXPERIMENTAL
Intervention: Readiness training activities
Number of subjects: 500

Group type: COMPARATOR
Intervention: Standard approach typically used at the facility
Number of subjects: 500
Study: 8780339

Group type: EXPERIMENTAL
Intervention: Resistant starch (RS2) 30 g/d
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Resistant starch (RS3) 30 g/d
Number of subjects: 57

Group type: COMPARATOR
Intervention: Glucose (control)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Resistant starch (RS2 and RS3)
Number of subjects: 57
Study: 1361083

Group type: EXPERIMENTAL
Intervention: Formoterol (12 mu/g) inhaled twice daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Salbutamol (200 mu/g) inhaled 4 times daily
Number of subjects: 40
Study: 3969207

Group type: EXPERIMENTAL
Intervention: Bromocriptine (20 mg maximum daily dosage)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Bromocriptine (average dosage of 13 mg)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 36
Study: 31564314

Group type: EXPERIMENTAL
Intervention: Blue light–filtering IOL (AcrySof IQ SN60WF)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Violet light–filtering IOL (OptiBlue ZCB00V)
Number of subjects: 55
Study: 29908888

Group type: EXPERIMENTAL
Intervention: Aerosolized Fibrin Sealant (FS)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 41
Study: 26953983

Group type: EXPERIMENTAL
Intervention: Watch-and-wait treatment (nonoperative treatment)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Total mesorectal excision
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Clinical and radiologic judgments of tumor response
Number of subjects: 118
Study: 23937957

Group type: EXPERIMENTAL
Intervention: 2-handed technique
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: modified 2-handed technique
Number of subjects: 52

Group type: COMPARATOR
Intervention: 1-handed technique
Number of subjects: 52

Group type: COMPARATOR
Intervention: 2-handed technique vs 1-handed technique
Number of subjects: 52

Group type: COMPARATOR
Intervention: modified 2-handed technique vs 1-handed technique
Number of subjects: 52
Study: 22083073

Group type: EXPERIMENTAL
Intervention: Raltegravir intensification
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 19237002

Group type: COMPARATOR
Intervention: low fat diet (1500kcal/day, 52% carbohydrates, 20% proteins, 27% fats)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: high fat and high protein diet (1507kcal/day, 38% carbohydrates, 26% proteins, 36% fats)
Number of subjects: 74
Study: 18277740

Group type: EXPERIMENTAL
Intervention: Oral-B Triumph with FlossAction brush head
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sonicare Elite 7300 with full-size brush head
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sonicare Elite 7300 with compact head
Number of subjects: 50
Study: 16305725

Group type: EXPERIMENTAL
Intervention: Budesonide 9 mg daily for 6 weeks
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Budesonide for treatment of clinical relapse
Number of subjects: 51
Study: 11943525

Group type: EXPERIMENTAL
Intervention: Postoperative continuous epidural droperidol infusion (2.5 mg/day)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Intraoperative single IV injection of droperidol (2.5 mg)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Intraoperative IV injection of droperidol (2.5 mg) and postoperative continuous epidural droperidol infusion (2.5 mg/day)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no droperidol)
Number of subjects: 120
Study: 9808279

Group type: EXPERIMENTAL
Intervention: Near-nerve SNC
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Surface antidromic SNC
Number of subjects: 82

Group type: COMPARATOR
Intervention: Statistical analysis
Number of subjects: 82

Group type: COMPARATOR
Intervention: Absent sensory potentials
Number of subjects: 82
Study: 8586132

Group type: EXPERIMENTAL
Intervention: Single Step Cold Air Challenge (SSCACh)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Multiple Step Cold Air Challenge (MSCACh)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Histamine Provocation
Number of subjects: 28
Study: 2545721

Group type: EXPERIMENTAL
Intervention: Polymyxin B treatment
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (24 burn patients)
Number of subjects: 12
Study: 775889

Group type: EXPERIMENTAL
Intervention: Thioridazine
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 30819170

Group type: EXPERIMENTAL
Intervention: Support arm (referral to a weight management group)
Number of subjects: 1882

Group type: COMPARATOR
Intervention: Advice arm (advice on health benefits of weight loss)
Number of subjects: 1882
Study: 27966784

Group type: EXPERIMENTAL
Intervention: JASPER intervention
Number of subjects: 113

Group type: COMPARATOR
Intervention: Treatment as usual waitlist
Number of subjects: 113
Study: 26267727

Group type: EXPERIMENTAL
Intervention: Desoximetasone 0.25% spray
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle spray
Number of subjects: 0
Study: 24279904

Group type: EXPERIMENTAL
Intervention: Lacprodan® PL-20 (milk protein concentrate rich in phospholipids)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Phospholipid-free milk protein concentrate (placebo)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Inert rice starch (placebo)
Number of subjects: 150
Study: 21347823

Group type: EXPERIMENTAL
Intervention: Sleeve Gastrectomy (SG)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Medical Treatment (MED)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Lean subjects (Control)
Number of subjects: 20
Study: 19108937

Group type: EXPERIMENTAL
Intervention: 100 mM sodium butyrate enema for 2 weeks
Number of subjects: 16

Group type: COMPARATOR
Intervention: Saline enema for 2 weeks
Number of subjects: 16
Study: 17207719

Group type: EXPERIMENTAL
Intervention: Fixed-dose combination of isosorbide dinitrate and hydralazine (FDC I/H)
Number of subjects: 0
Study: 15365070

Group type: EXPERIMENTAL
Intervention: Power Doppler ultrasound-directed lymph node excisional biopsy
Number of subjects: 152

Group type: COMPARATOR
Intervention: Standard excisional biopsy
Number of subjects: 152
Study: 11343440

Group type: EXPERIMENTAL
Intervention: Less than 30 minutes of physical activity per week
Number of subjects: 2336

Group type: COMPARATOR
Intervention: 30 or more minutes of physical activity per week
Number of subjects: 2336
Study: 9599360

Group type: EXPERIMENTAL
Intervention: 0.1% indomethacin
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 0.1% diclofenac
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 7973431

Group type: EXPERIMENTAL
Intervention: Clinical decision-making based on symptoms and physical examination
Number of subjects: 1333

Group type: EXPERIMENTAL
Intervention: Computer-based diagnostic score
Number of subjects: 1333

Group type: EXPERIMENTAL
Intervention: Previous abdominal surgery
Number of subjects: 1333

Group type: EXPERIMENTAL
Intervention: Type of pain (colic/intermittent versus steady)
Number of subjects: 1333

Group type: EXPERIMENTAL
Intervention: Abdominal distension (yes versus no)
Number of subjects: 1333

Group type: EXPERIMENTAL
Intervention: Bowel sounds (abnormal versus normal)
Number of subjects: 1333
Study: 2686411

Group type: EXPERIMENTAL
Intervention: Intravenous ciprofloxacin
Number of subjects: 44

Group type: COMPARATOR
Intervention: Ceftazidime
Number of subjects: 44
Study: 336052

Group type: EXPERIMENTAL
Intervention: Levamisole 100 mg 4 days a week for 4 months
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 29129554

Group type: EXPERIMENTAL
Intervention: Dichloroacetate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 27692144

Group type: EXPERIMENTAL
Intervention: Salbutamol (bronchodilator)
Number of subjects: 45

Group type: COMPARATOR
Intervention: None (Control group)
Number of subjects: 45
Study: 24659510

Group type: EXPERIMENTAL
Intervention: Standardised ECG criteria tool
Number of subjects: 62

Group type: COMPARATOR
Intervention: Usual interpretation
Number of subjects: 62
Study: 22152652

Group type: EXPERIMENTAL
Intervention: High-frequency audiometer (frequency range: 125‐18,000 Hz)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Conventional audiometer (frequency range: 125‐12,000 Hz)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: High-frequency audiometer
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Intensity of tinnitus
Number of subjects: 47
Study: 20150346

Group type: EXPERIMENTAL
Intervention: Aspirin (75 mg)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220
Study: 17880770

Group type: EXPERIMENTAL
Intervention: Zafirlukast for 6 months
Number of subjects: 120

Group type: COMPARATOR
Intervention: Vitamin E for 6 months
Number of subjects: 120